Extract notice to the Minister

Erivedge

Common name / Subject : vismodegib
Name of the manufacturer : Roche
Form : Caps.
Dosage : 150 mg

Indication : Carcinome basocellulaire

INESSS' Recommendation
Avis de refus d'inscription aux listes des médicaments

Minister's decisions
Ne pas inscrire aux listes des médicaments

Evaluation published on August 19, 2016

Download Advice to minister about Erivedge

Extrait de l'Avis au ministre sur Erivedge 105 KiO

Subscribe to our newsletter now

Subscription